RALLIS CHRIS A

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$196,813.67

Insider Activity of RALLIS CHRIS A

According to the SEC Form 4 filings, RALLIS CHRIS A, being in a position of

  1. director at Fennec Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13292 shares for $99,495,
    over all time since 2022-11-17, has bought 0 shares, and sold 25328 shares for $196,814.

The largest sale of all time was on 2023-07-24 and amounted to 6796 shares of Fennec Pharmaceuticals Inc. for $55,523.

Biography of RALLIS CHRIS A

No biography is available at this moment.

2024-12-02SaleFennec Pharmaceuticals Inc.
FENC
director
6,409
0.0225%
$6.14$39,351-2.72%
2024-10-08SaleFennec Pharmaceuticals Inc.
FENC
director
1,406
0.0045%
$4.53$6,369+5.43%
2024-07-05SaleFennec Pharmaceuticals Inc.
FENC
director
1,173
0.0043%
$6.03$7,0730%
2024-04-15SaleFennec Pharmaceuticals Inc.
FENC
director
800
0.003%
$10.45$8,360-41.28%
2024-03-26SaleFennec Pharmaceuticals Inc.
FENC
director
2,114
0.0079%
$10.97$23,191-43.72%
2023-12-26SaleFennec Pharmaceuticals Inc.
FENC
director
1,390
0.0049%
$10.90$15,151-41.03%
2023-11-20SaleFennec Pharmaceuticals Inc.
FENC
director
269
0.001%
$8.25$2,219+3.85%
2023-08-18SaleFennec Pharmaceuticals Inc.
FENC
director
673
0.0024%
$7.85$5,283+10.22%
2023-07-24SaleFennec Pharmaceuticals Inc.
FENC
director
6,796
0.0257%
$8.17$55,523+6.16%
2023-07-06SaleFennec Pharmaceuticals Inc.
FENC
director
2,207
0.0082%
$8.47$18,693+1.98%
2023-05-19SaleFennec Pharmaceuticals Inc.
FENC
director
1,758
0.0065%
$7.36$12,939+18.88%
2022-11-17SaleFennec Pharmaceuticals Inc.
FENC
director
333
0.0012%
$7.99$2,661+2.5%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.